Arnold I Pallay MD FAAFP
Medical Director, Changebridge Medical Associates a member of Consensus Health Associate Medical Director , Personalized Genomic Medicine Atlantic Health System Medical Director , VAXCARE, New Jersey
Join to View Full Profile
170 Changebridge RdBldg C3Montville, NJ 07045
Phone+1 973-575-5540
Fax+1 973-575-4885
Dr. Pallay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Arnold Pallay is a Montville, NJ-based family medicine specialist with extensive experience in medical genetics and population health management. He completed his medical education at Boston University School of Medicine and his residency in family medicine at Hackensack University Medical Center. Dr. Pallay serves as Executive Medical Director at Partners in Care and at Consensus Medical Group and has contributed to publications on Alzheimer's disease detection in primary care, polygenic risk scores for coronary artery disease, and the nutritional usage of vitamins. His involvement in clinical trials includes research on pharmacogenomics for reducing adverse drug effects. Over his career, he has received multiple CMS Meaningful Use Stage certifications and recognition from the National Committee for Quality Assurance for his practice management.
Education & Training
Hackensack University Medical Center (Mountainside)Residency, Family Medicine, 1983 - 1986
Boston University School of MedicineClass of 1983
Certifications & Licensure
NJ State Medical License 1984 - 2027
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification e-MDs Solution Series, eMDs, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification SmartClinic, VIP Medicine, LLC, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification e-MDs Cloud Solutions, eMDs, 2011, 2013-2017
Clinical Trials
- Utility of PharmacoGenomics for Reducing Adverse Drug Effects Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United States.Michelle M Mielke, H Ricky Kurzman, Yan Helen Hu, Min Cho, Jonathan Liss
Neurology. Clinical Practice. 2026-02-01 - Impact of polygenic risk score (PRS) for coronary artery disease on physician decision-making and patient care.Georgios Ntritsos, Erez Ornan, Nir Gamliel, Gil Chernin, Arnold Pallay
Frontiers in Genetics. 2025-01-01
Journal Articles
- Nutritional usage of VitaminsPallay, Arnold, Journal of family is Practice, 6/1983
Press Mentions
COD Addresses Medical Aid in Dying, Institutional RacismOctober 10th, 2018
One Million Solutions in Health™ Features Dr. Arnold Pallay Speaking on Advancing Genomic and Pharmacogenetic Medicine as Part of Precision MedicineJanuary 31st, 2017- Delegates Debate Membership IssuesSeptember 27th, 2013
Committees
- Member, Commission on Education 2018 - Present
- Member, AAFP Commission on Finance 2007 - 2011
Professional Memberships
- Fellow
- American Society for Human GeneticsMember
External Links
- VMGhttp://Vanguardmedgroup.com
- The Dr. Who Showhttps://m.youtube.com/watch?feature=share&v=QyqXODczetg
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
